COMMUNIQUÉS West-GlobeNewswire

DIL Walk Foundation Takes National and Global Leadership Role in Advancing Precision Health and Healthspan
11/02/2026
CALGARY, Alberta, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The DIL Walk Foundation is strengthening its leadership role in advancing precision health, longevity research, and healthspan-focused care, positioning Canada as an [...]
HNL Lab Medicine Opens New Patient Service Center at The Marketplace at Steamtown
11/02/2026
SCRANTON, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) -- HNL Lab Medicine is expanding access to convenient, high-quality laboratory services with the opening of a new Patient Service Center at The Marketplace at Steamtown, [...]
Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call
11/02/2026
NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today [...]
Laseroptek America Files Counterclaims Alleging Anticompetitive and Unfair Business Practices in Ongoing Litigation with Strata Skin Sciences
11/02/2026
LAGUNA HILLS, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Laseroptek America Corp. (“Laseroptek America” or “LOA”) today announced that it has filed counterclaims and third-party claims against Strata Skin Sciences, Inc [...]
Aveanna’s Heartways Program Receives CHAP Disease Program Certification
11/02/2026
ATLANTA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Community Health Accreditation Partner (CHAP), an independent, non-profit accrediting body for home and community-based healthcare, and Aveanna Healthcare (NASDAQ: AVAH), a [...]
Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership
11/02/2026
MELBOURNE, Australia and LAS VEGAS, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq”) and Healthy Extracts™ Inc. (“Healthy Extracts”) today announced the signing of a Memorandum of Understanding (“MoU”) [...]
LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026
11/02/2026
BURLINGTON, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2025 financial results on Wednesday, February 25, 2026, after the market [...]
SRx Health Solutions Redeems Series A Preferred Stock and Cancels Approximately 125,000,000 Shares of Common Stock, Improving Balance Sheet Flexibility for Investment in M&A or Return of Capital to Shareholders
11/02/2026
NORTH PALM BEACH, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that it has redeemed 17,500 shares of its Series A Preferred Stock pursuant to [...]
Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit
11/02/2026
NEEDHAM, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies [...]
Genvor’s AGM182 Antifungal Peptide Technology Validated in Peer-Reviewed Publication in PhytoFrontiers™
11/02/2026
Greenhouse trial results published jointly with USDA-ARS demonstrate 76-98% reduction in aflatoxin contamination in transgenic corn expressing the BioCypher-designed peptide AGM182 Woodland, CA, Feb. 11, 2026 (GLOBE [...]
VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego
11/02/2026
Company produces thorough reference testing on Antibody Drug Conjugates, showing high correlation with clinical liver and intestinal toxicity and side effects SAN DIEGO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, [...]
Denovo Biopharma Announces Partnership with Orygen on Phase 2 Study Evaluating DB103 (Pomaglumetad Methionil) in Treating Psychosis
11/02/2026
SAN DIEGO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Denovo Biopharma LLC, a pioneer in applying precision medicine to development of innovative drugs, today announced a partnership with Orygen to initiate a Phase 2 [...]
Counslr Meets School Mental Health Demands with Further National Expansion and Strategic Partnerships
11/02/2026
Text-based support Signals a Shift in School Mental Health Access NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Counslr , a leading B2B mental health and wellness platform , announced today a series of strategic [...]
iMDx Announces $26.0 Million Registered Direct Offering
11/02/2026
NASHVILLE, Tenn., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (“iMDx” or the “Company”), today announced that it has entered into definitive agreements with certain [...]
Biofrontera Announces FDA Filing Acceptance of Supplemental New Drug Application for Ameluz® PDT in Superficial Basal Cell Carcinoma
11/02/2026
Prescription Drug User Fee Act (PDUFA) target action date set for September 28, 2026 If approved, Ameluz ® would be the first and only PDT photosensitizer indicated for the treatment of superficial Basal Cell Carcinoma [...]
Wesley Pharmaceuticals Launches NAD+, Introducing a Signature Longevity and Skin Health Formulation to Its Product Lineup
11/02/2026
The premier 503B facility streamlines clinical access to its flagship NAD+ injection, offering an innovative wellness solution for Wesley’s nationwide client base ORLANDO, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Wesley [...]
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
11/02/2026
The Company will Host a Conference Call and Webcast on Thursday, February 26, 2026, at 8:30 AM ET CORAL GABLES, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: [...]
Telehealth Now Available for DARE to PLAY™ Sildenafil Cream: First Evidence-Based Topical Arousal Cream for Women
11/02/2026
Pre-Fulfillment Prescribing Now Available in All 50 States, Supporting National Launch Developed and evaluated specifically for women, DARE to PLAY™ Sildenafil Cream is a first-of-its-kind female arousal cream, a non- [...]
Helus Pharma nomme Michael Cola au poste de directeur général pour piloter la prochaine phase de développement et d’exécution
11/02/2026
Ancien président de la division pharmaceutique spécialisée de Shire PLC (« Shire »), il cumule plus de 30 ans d’expérience dans les domaines des neurosciences, des maladies rares et des produits pharmaceutiques [...]

Pages